Evidence map›Paper›PMID 38026538›Full record

ReviewInternational journal of nanomedicine2023

Nanotechnology-Based Drug Delivery Systems for Honokiol: Enhancing Therapeutic Potential and Overcoming Limitations.

Jing Yang, Jinlu Shang, Liuxuan Yang, Daiqing Wei, Xia Wang, Qinmin Deng, Zhirong Zhong, Yun Ye, Meiling Zhou

Open access · goldAbstract readReview
In one paragraph

Review in International journal of nanomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jing Yang *Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Jinlu Shang *Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Liuxuan Yang *Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Daiqing WeiDepartment of Orthopaedics, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Xia WangDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Qinmin DengDepartment of Clinical Pharmacy, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Zhirong ZhongDepartment of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, People's Republic of China.ORCID 0000-0003-1509-4540
Yun YeDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Meiling ZhouDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.ORCID 0000-0002-0559-2450
Southwest Medical University · CNAffiliated Hospital of Southwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Honokiol (HNK) is a small-molecule polyphenol that has garnered considerable attention due to its diverse pharmacological properties, including antitumor, anti-inflammatory, anti-bacterial, and anti-obesity effects. However, its clinical application is restricted by challenges such as low solubility, poor bioavailability, and rapid metabolism. To overcome these limitations, researchers have developed a variety of nano-formulations for HNK delivery. These nano-formulations offer advantages such as enhanced solubility, improved bioavailability, extended circulation time, and targeted drug delivery. However, existing reviews of HNK primarily focus on its clinical and pharmacological features, leaving a gap in the comprehensive evaluation of HNK delivery systems based on nanotechnology. This paper aims to bridge this gap by comprehensively reviewing different types of nanomaterials used for HNK delivery over the past 15 years. These materials encompass vesicle delivery systems, nanoparticles, polymer micelles, nanogels, and various other nanocarriers. The paper details various HNK nano-delivery strategies and summarizes their latest applications, development prospects, and future challenges. To compile this review, we conducted an extensive search using keywords such as "honokiol", "nanotechnology", and "drug delivery system" on reputable databases, including PubMed, Scopus, and Web of Science, covering the period from 2008 to 2023. Through this search, we identified and selected approximately 90 articles that met our specific criteria.

Indexed as

LignansNanoparticlesAllyl CompoundsBiphenyl CompoundsDrug Delivery SystemsMicellesNanotechnologyPhenolsAllyl CompoundsBiphenyl CompoundshonokiolLignansMicellesPhenolsantitumorbioavailabilitydrug deliveryhonokiolnanotechnologytargeting

Identifiers

PMID38026538
PMCPMC10656744
OpenAlexW4388639518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.